Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01S—RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
  • G01S7/00—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00
  • G01S7/52—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00 of systems according to group G01S15/00
  • G01S7/52017—Details of systems according to groups G01S13/00, G01S15/00, G01S17/00 of systems according to group G01S15/00 particularly adapted to short-range imaging
  • G01S7/52023—Details of receivers
  • G01S7/52025—Details of receivers for pulse systems
  • G01S7/52026—Extracting wanted echo signals
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
  • A61B8/12—Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters

Definitions

• This invention relates to ultrasonic imaging and more particularly to suppression of spurious artifact signals at ranges close to an excitation source, herein known as ring- down artifact.
• Ring-down artifact is caused by transients associated with an exciter which cause interference with informational signals reflected from sources close to the exciter (echo signals) .
• echo signals informational signals reflected from sources close to the exciter
• undesired ring-down artifact can impede accurate imaging.
• One known mechanism for eliminating ring-down artifact is to gate on the echo signal so that all artifacts are eliminated m the close- m region where ring-down is expected to occur.
• useful echo signals are also eliminated by gating.
• rmg-down artifact is reduced or eliminated by dynamically enhancing the ring-down over a plurality of scans, and then determining the ring-down range by keying on a ⁇ ng- down-to-blood transition characterized by a rapid change from high amplitude to low amplitude echoes.
• a ring-down pattern is computed for a single or several A- scans within the nng- down range, using for example an FFT analysis, and then selectively filtering subsequent images using the recently computed ring-down pattern.
• the invention provides a method for filtering an m-vivo ultrasonic signal.
• an ultrasonic signal is emitted and a return signal is collected which includes at least an artifact component and a blood component.
• a transition region in the collected return signal is then identified, with the transition region having the artifact component and the artifact component combined with the blood component.
• a ring- down pattern m the transition region is then determined based at least m part on the artifact component. Once the ring- down pattern is identified, at least some of (and preferably substantially all of) the artifact component is filtered from the collected return signal based on the ring-down pattern.
• the transition region is preferably identified by examining amplitude patterns m the collected return signal.
• the signal may be analyzed to determine a rapid change from high amplitude to low amplitude.
• the return signal will include a low frequency, high amplitude pattern which is indicative of the ring-down artifact, and a high frequency, low amplitude pattern which is indicative of blood.
• the point at which such a change is detected is referred to as a transition point and divides the signal into the transition region and a target or blood region.
• spectral patterns m the collected return signal may also be examined.
• Use of the spectral patterns can assist m identifying the transition region after the transition point has been identified or approximated.
• a catheter is introduced into a body lumen and an ultrasonic source is excited within the catheter to emit the ultrasonic signal.
• the artifact component is enhanced so that the artifact component is readily identified. This may be done mechanically by repositioning the ultrasonic source. Enhancement may also occur electronically or by software. For example, the emitting and collecting steps may be repeated at different locations to obtain multiple scans. These scans are then convolved to dynamically enhance a pattern of ring-down artifacts as an accumulated ring-down pattern.
• the ring-down pattern is stored for use m analyzing subsequent scans.
• the stored ring-down pattern for is then used for filtering where a ring-down-to- blood transition is not found in a subsequent scan.
• the step of determining the ring-down pattern comprises obtaining a Fourier transform of the transition region and the blood region of the collected return signal and subtracting the transformed blood region from the transformed transition region.
• Fig. 1 is a block diagram illustrating a device operative according to the invention for identifying the ring- down region.
• Fig- 2 is a graph illustrating a scan having a ring- down artifact region a target region and a transition region between the artifact region and the target region.
• Fig. 3 is the graph of Fig. 2 showing a ring-down pattern m the transition region.
• Fig. 4 is the graph of Fig. 2 with the ring-down pattern filtered out .
• Fig. 5 is a graph illustrating another scan generated with the ultrasonic source being adjacent tissue.
• Fig. 6 is the graph of Fig. 5 having the ring-down pattern of Fig. 3 being filtered out.
• Fig. 7 is a flow chart of the steps according to the inventive method.
• the invention provides exemplary systems and methods for suppressing spurious artifact signals at ranges close to an excitation source.
• the invention will find its greatest use with ultrasonic imaging elements which are disposed within catheters, and particularly, imaging catheters employed to produce images of the vascular anatomy.
• imaging catheters include an imaging element that is held within a housing. As the imaging element is excited, transients reflected from the housing interfere with the signals reflected from objects within the anatomy, such as blood, vessel walls, and the like.
• the invention is able to substantially reduce or eliminate the ring-down artifact caused by such transient signals.
• FIG. 1 there is shown basic elements of a simple mtravascular ultrasonic (IVUS) imaging system 10 providing imaging of the interior 12 of a vascular subject 14, as shown m an enlarged cross-section.
• a catheter 16 contains electrical conduits 18 that communicate between a transducer 20 and a console 22 housing an exciter source 24, a receiver 26 a signal processor 28 with associated controls, the output of which is provided to an output device 30, such as a television monitor or a computer display or a combination thereof.
• the exciter source 24 generates ultrasonic excitation signals 32 of a finite duration that are applied to the transducer 20, which in turn directs those excitation signals 32 in a generally-defined directional beam.
• Ultrasonic artifact signal 34 is reflected from the interior of the space under observation to be intercepted by the transducer 20, inducing an electrical report which is recovered by the receiver 26 m the console 22.
• the electrical signals recovered are analyzed by a signal processor 28 operative according to the invention to present an output to the output device 30 which is preferably a reconstructed two-dimensional image of the target cross-section displayed m near real-time.
• An exemplary medical imaging system that may be used to implement the techniques of the invention is a Galaxy medical imaging system, commercially available from Boston Scientific Corporation.
• the transducer 20 may be an array disposed around the skin of the catheter 16, or a single transducer or transducer set which might rotate around the skin of the catheter.
• the signal which is emitted from the transducer is referred to as an A- scan.
• the detected signal along any axis can be reconstructed as the sum of the echo and ring-down artifact which is an amplitude as a function of time.
• Fig. 2 is a graph of a trace 40, m this case a convoluted A-scan, and includes both ring-down artifact and echo signal.
• a scan is typical of a scan produced when the transducer is separated from a target region (such as plaque) by blood.
• the segment I of trace 40 represents pure ring-down.
• the segment R of trace 40 represents the portion of the overlap of contribution of echo and ring-down, that is, the region where echo begins before the transducer 20 settles.
• the combination of segments I and R are referred to as the transition region.
• the segment T is the pure echo without ring-down of the target, which m this case is blood.
• the ring-down contribution or pattern is determined as shown m Fig. 3, then its contribution is subtracted from the composite echo signal in order to yield a more accurate image of the target area as shown m Fig. 4.
• the ring-down artifact may be characterized in the time domain and/or the time domain across consecutive scans: several sequential scans are convolved or otherwise averaged together to determine the nature of any repetitive artifacts while canceling any short-term artifacts.
• the resultant convoluted ring-down pattern (see Fig. 3) is subtracted from the current scan report to yield a scan report 42 with ring- down effectively eliminated, as shown m Fig. 4.
• the computation of the ring-down pattern is made for scans for which the following assumption holds: along the A- scan axis, tissue does not intervene between the transducer and the blood region nearest the transducer, such as for example, in Fig. 2.
• rmg-down and blood echoes are present .
• the typical transition from rmg-down to blood echo can be identified by the distinction between signals produced by rmg-down and produced by blood.
• the signals produced by ring- down are high amplitude oscillations of relatively low frequency.
• the signals produced by blood are of low amplitude and high frequency.
• the rmg-down contribution is represented by the crossed hatched area in Fig. 2.
• the rmg-down signal may detrimentally overload the finite, lower-amplitude echo from the target region.
• the previous assumption does not hold because tissue exists near the transducer.
• a previously computed and stored rmg-down pattern (such as the pattern of Fig. 3) is used for selective filtering.
• Fig. 5 is a graph of a trace 44 where the transducer is adjacent tissue.
• the pattern of Fig. 3 which was previously computed, is used for selective filtering.
• the result is illustrated m Fig. 6 which includes only the signal of the target.
• FIG. 7 there is shown a flow chart of a signal processing technique according to the invention.
• the data on a plurality of frames of R- ⁇ data is collected (Step A) , and the latest frame is preferably selected as the current frame for processing (Step B) .
• the ring-down artifact may be enhanced so it can be more easily characterized (Step C) . This may be done mechanically by repositioning the transducer to zero tilt, whereas a slight tilt is normally preferred to suppress such artifact. Enhancement may also be done electronically or by software by the process of convolving several sequential A- scans .
• Step D the A-scan is inspected to determine the presence of the transition region of rmg-down to blood. This can be an iterative process of examining the time domain signal searching for the boundary between rapid high-amplitude transitions and low-amplitude transitions.
• the transition between the transition region and the blood region is referred to as a transition point, such as point 48 on Fig. 2.
• such an amplitude analysis may serve only as a first approximation of the transition point. If so, a second processes may be employed to further define the transition point. For example, the estimated target point may be varied and a fast Fourier transform may be performed on the target region T and on the transition region I and R (see Fig. 2) to covert the time-domain data to frequency-domain data for each variation. This process may be repeated until consistent results are obtained.
• the rmg-down artifact pattern the transition region is computed (Step E) . This may be done dynamically by computing the rmg-down pattern for one A-scan within the ring-down range.
• a straightforward fast Fourier transform (FFT) of the transition region and the target region may be used for frequency domain analysis. Such an FFT computation can be performed periodically during real-time imaging for each individual A-scan following other filtering processes, such as blood speckle reduction.
• a weignted subtraction is performed to selectively filter out the ring down pattern (such as is shown m Fig. 3) .
• the ring down pattern is preferably saved, and the filtered data is converted back to the time domain to produce the signal shown m Fig. 4.
• the rmg-down pattern is preferably saved and/or updated for use in the cases where a ring-down-to-blood transition is lacking, e.g., where there is tissue residing next to the transducer (Step F) as shown, for example, m Fig. 5. If there is no rmg-down-to-blood transition present, the system checks to see if there is already a rmg-down pattern available or previously stored (Step G) . If not, the process begins again (Step A) until a pattern emerges, e.g., after a ring-down-to-blood transition is found.
• rmg-down artifact is suppressed by a selective filtering, i.e., by subtraction of the ring-down contribution from the signal, to yield a filtered image (Step H) .
• a selective filtering i.e., by subtraction of the ring-down contribution from the signal.

Landscapes

• Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• Life Sciences & Earth Sciences (AREA)
• Physics & Mathematics (AREA)
• Pathology (AREA)
• Heart & Thoracic Surgery (AREA)
• Radar, Positioning & Navigation (AREA)
• General Physics & Mathematics (AREA)
• Biophysics (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Computer Networks & Wireless Communication (AREA)
• Radiology & Medical Imaging (AREA)
• Biomedical Technology (AREA)
• Remote Sensing (AREA)
• Medical Informatics (AREA)
• Molecular Biology (AREA)
• Surgery (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Ultra Sonic Daignosis Equipment (AREA)

Priority Applications (4)

Applications Claiming Priority (2)

Publications (1)

Family

ID=22600563

Family Applications (1)

Country Status (6)

Cited By (2)

Families Citing this family (90)

Citations (3)

Family Cites Families (9)

• 1998
  • 1998-10-02 US US09/165,807 patent/US6102862A/en not_active Expired - Lifetime
• 1999
  • 1999-09-13 DE DE69927040T patent/DE69927040T2/de not_active Expired - Lifetime
  • 1999-09-13 EP EP99940432A patent/EP1117332B1/en not_active Expired - Lifetime
  • 1999-09-13 WO PCT/IB1999/001542 patent/WO2000019904A1/en not_active Ceased
  • 1999-09-13 CA CA2340246A patent/CA2340246C/en not_active Expired - Fee Related
  • 1999-09-13 JP JP2000573267A patent/JP4463422B2/ja not_active Expired - Lifetime
• 2000
  • 2000-07-25 US US09/625,149 patent/US6254543B1/en not_active Expired - Lifetime
• 2001
  • 2001-05-18 US US09/860,907 patent/US6589181B2/en not_active Expired - Lifetime

Patent Citations (3)

Also Published As

Similar Documents

Legal Events